Half-Life of Nortriptyline
Pharmacokinetic Parameters
The elimination half-life of nortriptyline in adults ranges from 14 to 51 hours under normal therapeutic conditions, with most patients experiencing a half-life of approximately 30-36 hours. 1
Key Clinical Considerations
Standard Therapeutic Dosing
- Under normal therapeutic conditions with doses of 10-25 mg daily, nortriptyline demonstrates a half-life of approximately 30-36 hours in most patients 2
- This relatively long half-life allows for once-daily or twice-daily dosing regimens 1
- Steady-state plasma concentrations are typically achieved within approximately 5-7 days (approximately 5 half-lives) 1
Factors Affecting Half-Life
Age and renal function significantly impact nortriptyline elimination, as metabolite clearance is ultimately dependent on renal elimination 3. Elderly patients may experience:
- Accumulation of hydroxy-metabolites due to reduced renal function 3
- Increased risk of cardiovascular and other toxicities from metabolite accumulation 3
Toxic Ingestions and Overdose
In massive overdose situations, nortriptyline pharmacokinetics become highly unpredictable and the half-life can be dramatically prolonged. 4
- A documented case demonstrated an elimination half-life of 184 hours (approximately 7.7 days) following a massive overdose of 2500 mg 4
- This represents more than a 3-fold increase compared to therapeutic dosing 4
- The prolonged half-life in overdose is attributed to:
Capacity-Limited Metabolism
Nortriptyline exhibits dose-dependent (nonlinear) pharmacokinetics in some patients, even at therapeutic doses. 2
- One case report documented half-lives increasing from 30.4 hours at 10 mg every other day to 64 hours at 25 mg daily 2
- This capacity-limited metabolism means that small dose increases can result in disproportionately large increases in plasma concentrations 2
Drug Interactions
Drug interactions can dramatically prolong nortriptyline half-life through cytochrome P450 inhibition. 5
- Fluoxetine and its long-acting metabolite norfluoxetine can cause severe, slowly reversible inhibition of nortriptyline metabolism 5
- One case documented an amitriptyline (parent compound of nortriptyline) half-life of approximately 120 hours when combined with fluoxetine, even in a patient with normal CYP2D6 function 5
Clinical Implications for Discontinuation
When discontinuing nortriptyline, a gradual taper over 10-14 days is recommended to minimize withdrawal symptoms, similar to other antidepressants with moderate half-lives 6
Important Caveats
- Do not rely on standard pharmacokinetic parameters to guide clinical decisions in overdose situations 4
- In toxic ingestions, urine tricyclic antidepressant screens and QRS duration provide more reliable guidance than calculated half-lives 4
- Therapeutic drug monitoring should occur at steady state (approximately 1 week after stable dosing) with samples collected 12-16 hours after the last dose 7
- The therapeutic window for nortriptyline is narrow (50-150 ng/mL), making monitoring particularly important 1